2017
DOI: 10.1172/jci89914
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic shifts in residual breast cancer drive tumor recurrence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

10
130
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 142 publications
(140 citation statements)
references
References 47 publications
10
130
0
Order By: Relevance
“…This metabolic change is modulated by oncogenic signaling pathways and promotes tumor initiation and progression, since cellular growth is dependent on the sustained availability of lipids (33). Moreover, metabolic shifts in lipid metabolism drive tumor recurrence after therapeutic intervention (34). Alterations in de novo lipid biosynthesis are associated with cancer pathogenesis (35).…”
Section: Discussionmentioning
confidence: 99%
“…This metabolic change is modulated by oncogenic signaling pathways and promotes tumor initiation and progression, since cellular growth is dependent on the sustained availability of lipids (33). Moreover, metabolic shifts in lipid metabolism drive tumor recurrence after therapeutic intervention (34). Alterations in de novo lipid biosynthesis are associated with cancer pathogenesis (35).…”
Section: Discussionmentioning
confidence: 99%
“…A higher degree of oxidative stress (OS) may be responsible for damages to nucleic acids, proteins and lipids, thus affecting cellular signaling pathways . Possible involvement of OS in the recurrence of BC has been suggested . Taken together, it is assumed that protein markers involved in lipid metabolism might serve as a therapeutic target in lowering risks of recurrence in patients with BC.…”
Section: Discussionmentioning
confidence: 99%
“…The progression of the field towards the cultivation of primary mammary cells [10,11] and the advantages compared to work with cell-lines was discussed. Lastly, Dr. Jechlinger highlighted the importance of analysing tumour progression in the appropriate 3D cellular context and the possibility of doing so with primary mammary cells using approaches that show good correlation with in vivo results from the parental mouse model [12].…”
Section: Day Threementioning
confidence: 99%